Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma.

Shao H, Chung J, Lee K, Balaj L, Min C, Carter BS, Hochberg FH, Breakefield XO, Lee H, Weissleder R. · 2015

Read Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. by Shao H, Chung J, Lee K, Balaj L, Min C, Carter BS, Hochberg FH, Breakefield XO, Lee H, Weissleder R. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4430127.txt.

Description

Huilin Shao and nine co-authors described a blood test chip for brain tumor drug response in Nature Communications in 2015. Glioblastoma is the most common primary brain cancer in adults, and doctors cannot easily re-sample the tumor to see if treatment works. Two repair enzymes, MGMT and APNG, undo damage from the main drug, temozolomide, so high levels predict poor response.

The chip captures tiny vesicles shed by tumor cells from blood and reads the enzymes' message RNA inside them. Those levels matched levels in the parent tumor cells and shifted notably during treatment in the small group of patients tested. If larger studies confirm the pattern, a blood draw could warn doctors early that a tumor is resisting the drug, without new brain surgery.

Catalog record

CREATORShao H, Chung J, Lee K, Balaj L, Min C, Carter BS, Hochberg FH, Breakefield XO, Lee H, Weissleder R.
YEAR2015
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4430127

Browse the full library · About the Tower of Babel